Cuba says it has developed a treatment for the Hepatitis C virus that would contribute to a long-term cure of liver damage caused by the disease.
The Havana-based Center for Genetic Engineering and Biotechnology said the product is a combination of Alpha-2B interferon and Rivairina, developed in the country.
The combination of these two formulas allows for an increased therapeutic response in people suffering from chronic hepatitis.
Doctors say Cuban patients can now rely on an alternative treatment that increases possibilities to control the illness.
He said the objective is to wipe out the virus circulating in the patient’s blood.
Clinical trials of the product were carried out at the National Gastroenterology Institute in Cuba.